Colin’s career has focused on understanding the causes of brain disease, with recent work exploring the neurobiology of compulsive disorders. He has long been interested in electronics and experimental methods, developing expertise in measuring neuronal activity. Colin is now applying his expertise in molecular biology, neural circuits and behavioural psychology to develop next-generation treatments for OCD.
Currently there are only two main treatment options for OCD: therapy and medication, both of which are ineffective in up to half of patients. Colin aims to change this.
Colin will explore the use of precision optics to develop new, minimally invasive treatments for OCD. Having witnessed the effects of OCD first-hand, Colin’s vision is to empower OCD patients with an effective, personalised, and anytime treatment option.
